Related references
Note: Only part of the references are listed.Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2-Radiological features and metric markers
Clara Le Fevre et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas
S. Schoen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
BraTS Toolkit: Translating BraTS Brain Tumor Segmentation Algorithms Into Clinical and Scientific Practice
Florian Kofler et al.
FRONTIERS IN NEUROSCIENCE (2020)
Deep learning for medical image analysis: a brief introduction
Benedikt Wiestler et al.
NEURO-ONCOLOGY ADVANCES (2020)
Consistency of normalized cerebral blood volume values in glioblastoma using different leakage correction algorithms on dynamic susceptibility contrast magnetic resonance imaging data without and with preload
Dennis Hedderich et al.
JOURNAL OF NEURORADIOLOGY (2019)
Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study
Philipp Kickingereder et al.
LANCET ONCOLOGY (2019)
18F-Fluoroethyl-tyrosine uptake is correlated with amino acid transport and neovascularization in treatment-naive glioblastomas
Friederike Liesche et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurement
Ken Chang et al.
NEURO-ONCOLOGY (2019)
On the promise of artificial intelligence for standardizing radiographic response assessment in gliomas
Benjamin M. Ellingson
NEURO-ONCOLOGY (2019)
Artificial Intelligence in the Management of Glioma: Era of Personalized Medicine
Houman Sotoudeh et al.
FRONTIERS IN ONCOLOGY (2019)
Quantitative biparametric analysis of hybrid 18F-FET PET/MR-neuroimaging for differentiation between treatment response and recurrent glioma
Johannes Lohmeier et al.
SCIENTIFIC REPORTS (2019)
Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy
Shanshan Jiang et al.
CLINICAL CANCER RESEARCH (2019)
Diagnosis of glioma recurrence using multiparametric dynamic 18F-fluoroethyl-tyrosine PET-MRI
Thomas Pyka et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography
Ji Eun Park et al.
EUROPEAN RADIOLOGY (2018)
Prediction of Pseudoprogression versus Progression using Machine Learning Algorithm in Glioblastoma
Bum-Sup Jang et al.
SCIENTIFIC REPORTS (2018)
Intra-lesional spatial correlation of static and dynamic FET-PET parameters with MRI-based cerebral blood volume in patients with untreated glioma
Jens Goettler et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging
Osamu Togao et al.
EUROPEAN RADIOLOGY (2017)
Amide Proton Transfer Imaging of Brain Tumors Using a Self-Corrected 3D Fast Spin-Echo Dixon Method: Comparison With Separate B0 Correction
Osamu Togao et al.
MAGNETIC RESONANCE IN MEDICINE (2017)
Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume
Yoon Seong Choi et al.
EUROPEAN RADIOLOGY (2017)
Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment?
Marcus Unterrainer et al.
EJNMMI RESEARCH (2017)
Updated response assessment criteria for high-grade glioma: beyond the MacDonald criteria
Mayur Sharma et al.
CHINESE CLINICAL ONCOLOGY (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma
Kye Jin Park et al.
EUROPEAN RADIOLOGY (2016)
Analysis of three leakage-correction methods for DSC-based measurement of relative cerebral blood volume with respect to heterogeneity. in human gliomas
Anne Kluge et al.
MAGNETIC RESONANCE IMAGING (2016)
Multiparametric MRI-based differentiation of WHO grade II/III glioma and WHO grade IV glioblastoma
Benedikt Wiestler et al.
SCIENTIFIC REPORTS (2016)
Standardized MRI assessment of high-grade glioma response: a review of the essential elements and pitfalls of the RANO criteria
Dewen Yang
NEURO-ONCOLOGY PRACTICE (2016)
Tumour progression or pseudoprogression? A review of post-treatment radiological appearances of glioblastoma
S. Abdulla et al.
CLINICAL RADIOLOGY (2015)
The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma
Norbert Galldiks et al.
NEURO-ONCOLOGY (2015)
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET
Norbert Galldiks et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients
Markus Hutterer et al.
NEURO-ONCOLOGY (2015)
Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Radiation Therapy and Concomitant Temozolomide: Comparison Study of Standard and High-b-Value Diffusion-weighted Imaging
Hee Ho Chu et al.
RADIOLOGY (2013)
Pseudoprogression in Patients With Glioblastoma Multiforme After Concurrent Radiotherapy and Temozolomide
Erkan Topkan et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2012)
Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [18F]FET-PET imaging in intracranial WHO grade II and III gliomas
Nathalie L. Jansen et al.
NEURO-ONCOLOGY (2012)
In Vivo Correlation of Tumor Blood Volume and Permeability with Histologic and Molecular Angiogenic Markers in Gliomas
R. Jain et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2011)
Support Vector Machine Multiparametric MRI Identification of Pseudoprogression From Tumor Recurrence in Patients with Resected Glioblastoma
Xintao Hu et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2011)
Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides
Jinyuan Zhou et al.
NATURE MEDICINE (2011)
Hot spots in dynamic 18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas
M. Kunz et al.
NEURO-ONCOLOGY (2011)
A reproducible evaluation of ANTs similarity metric performance in brain image registration
Brian B. Avants et al.
NEUROIMAGE (2011)
Neuroradiological Response Criteria for High-grade Gliomas
K. Lutz et al.
CLINICAL NEURORADIOLOGY (2011)
The SRI24 Multichannel Atlas of Normal Adult Human Brain Structure
Torsten Rohlfing et al.
HUMAN BRAIN MAPPING (2010)
Label Fusion in Atlas-Based Segmentation Using a Selective and Iterative Method for Performance Level Estimation (SIMPLE)
Thomas Robin Langerak et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Changes in Relative Cerebral Blood Volume 1 Month after Radiation-Temozolomide Therapy Can Help Predict Overall Survival in Patients with Glioblastoma
Rajiv Mangla et al.
RADIOLOGY (2010)
Posttreatment High-Grade Glioma: Usefulness of Peak Height Position with Semiquantitative MR Perfusion Histogram Analysis in an Entire Contrast-enhanced Lesion for Predicting Volume Fraction of Recurrence
Ho Sung Kim et al.
RADIOLOGY (2010)
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Dieto Brandsma et al.
LANCET ONCOLOGY (2008)
Share Paper
